Cepheid (company)
Company type | Public |
---|---|
Nasdaq: CPHD | |
Industry | Scientific & Technical Instrument |
Founded | 1996 |
Headquarters | United States |
Key people | Mr. John L. Bishop |
Revenue | $401.29 million (As of 2013[update])[1] |
Website | http://www.cepheid.com |
Cepheid Inc. (Nasdaq: CPHD) is a global molecular diagnostic system manufacturer and supplier. The company was founded in 1996 and is headquartered in Sunnyvale, California.[2] It was the winner of 2006 Industrial Design Excellence Awards for its product, Reagent Bead Dispenser.[3]. It won the federal contract by “MRSA Reagent Test Kits" in 2012.[4] One of the company’s customer is U.S. Food and Drug Administration (FDA). [5]
Background
The company provides integrated testing systems for a worldwide clinical market and for applications in the legacy non-clinical market. The two major products of the company include GeneXpert and SmartCycler. The two system applies similar method of DNA amplification and detection but the latter is developed for a wider range of customers.[6] The company offers tests for over 6 areas including healthcare associated infections and sexual health. The company serves tests of U.S. Food and Drug Administration (FDA) cleared products. [5] As of March 2014, the company has a market capitalization of $ 3.14 billion and an Enterprise value of $2.91 billion.[1] On Dec. 6, 2013, Trade-Ideas LLC identified the company as a new lifetime high candidate for its stock performance. [7]
References
- Notes
- ^ a b "CPHD Key Statistics | Cepheid, Inc Stock - Yahoo! Finance". Finance.yahoo.com. Retrieved 2014-03-09.
- ^ "CPHD: Summary for CEPHEID- Yahoo! Finance". Finance.yahoo.com. Retrieved 2014-03-09.
- ^ "2006 Industrial Design Excellence Awards". Markets.financialcontent.com. 2006-07-05. Retrieved 2014-03-09.
- ^ "Contract Award: Cepheid Wins Federal Contract for "MRSA Reagent". Highbeam.com. 2012-04-16. Retrieved 2014-03=09.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ a b "Cepheid (CPHD.O) Company Profile Reuters.com". Reuters.com. Retrieved 2014-03-09.
- ^ "Cepheid: NASDAQ:CPHD quotes & news - Google Finance". Google.com. Retrieved 2014-03-09.
- ^ "New Lifetime High Today: Cepheid (CPHD)". 2013-12-06. Retrieved 2014-03-09.